About the company
Adlore is designing the next generation device for the treatment of lower extremity difficult to heal wounds, i.e. diabetic/neuropathic foot ulcers, venous stasis leg wounds, arterial and ischemic ulcers. This device will incorporate Adlore’s proprietary SenLore™ technology to improve healing rates by supplying heat, thermo-regulated electrical pulse stimulation to increase blood flow, and a feedback sensor to monitor performance. The performance information will be communicated to the patient via a proprietary APP and via Wi-Fi to the clinician. The Adlore device will change how wounds are treated, improve patient well-being, and reduce health care costs.
Transaction Details
Transaction:
01/08/2020
Investment Fund:
Birmingham Angels
$$ Committed:
Confidential!
Stage:
Seed / Pre- Revenue
Type: